Cargando…
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
Irritable bowel syndrome is a group of functional gastrointestinal disorders with not yet fully clarified etiology. Recent evidence suggesting that mast cells may play a central role in the pathogenesis of irritable bowel syndrome paves the way for agents targeting histamine receptors as a potential...
Autores principales: | Fabisiak, Adam, Włodarczyk, Jakub, Fabisiak, Natalia, Storr, Martin, Fichna, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503283/ https://www.ncbi.nlm.nih.gov/pubmed/28551943 http://dx.doi.org/10.5056/jnm16203 |
Ejemplares similares
-
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016) -
Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract
por: Szymaszkiewicz, Agata, et al.
Publicado: (2020) -
Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases
por: Fabisiak, Natalia, et al.
Publicado: (2020) -
Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice
por: Salaga, Maciej, et al.
Publicado: (2021) -
Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain
por: Zielińska, Anna, et al.
Publicado: (2018)